Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 976 participants.

Also called NCT07290751

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 976 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07290751
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07290751. Randomized; quadruple masking; primary purpose treatment. Start 2025-11-11 (actual); primary completion 2026-10-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
Tirofiban
Intervention (Other)
Placebo (0.9% normal saline)
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct07290751
Content hash
22f4a9398ccf662194f0c2de5ae379ce404063949e9fb23bb14be6971ecf62ed